DSIP Peptide: What It Is, How It Works, and What the Evidence Shows

Delta sleep-inducing peptide (DSIP) is a small 9-amino-acid neuropeptide first isolated from rabbit brain in 1974 and studied for sleep regulation, chronic pain, stress response, and hormone modulation. Human evidence — especially for insomnia — is limited and mixed. DSIP is not FDA-approved for any indication in the United States, and material sold online is almost always labeled 'research use only,' which is not legal for human use [1][2].

What is DSIP peptide?

DSIP is a neuropeptide — a short chain of amino acids that brain cells use to signal one another. Its sequence is Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, which makes it small enough to cross the blood-brain barrier in animal studies [1].

Where DSIP was discovered

Swiss researchers Schoenenberger and Monnier isolated DSIP in 1974 from the blood of rabbits whose thalamus had been electrically stimulated to induce sleep. They named it for the slow, delta-frequency brain waves that appeared in deep sleep after infusion [1].

Structure and how it works in the body

DSIP is found naturally in the human brain, gut, and other tissues. Its exact receptor has not been confirmed. Research suggests it may interact with NMDA receptors, modulate glucocorticoid (stress hormone) regulation, influence MAO-A activity, and engage the endogenous opioid system [1][3]. Some work has noted homology with GILZ, a glucocorticoid-induced protein, hinting at a stress-axis role [1].

What are the benefits of DSIP peptide?

Most DSIP research is from the 1980s and 1990s, with small sample sizes and inconsistent results. Below is what the literature actually shows — not what marketing pages claim.

Sleep and slow-wave activity

DSIP is named for sleep, but the human data is underwhelming. Some early trials reported modest gains in sleep efficiency in people with chronic insomnia, while others found no meaningful effect on sleep latency, total sleep time, or REM sleep [3][4]. A 1984 controlled study in chronic insomniacs reported improvements on some sleep measures but not others, and the effect did not consistently outperform placebo [4].

Chronic pain and migraine

DSIP has been studied as an add-on for chronic pain, migraine, and opioid withdrawal, with researchers proposing an opioid-system mechanism [1][3]. Reported benefits are preliminary and based on small cohorts. Side effects in these studies were generally mild but were not systematically tracked.

Stress, mood, and hormone effects

Animal and limited human data suggest DSIP may blunt stress-hormone (cortisol) spikes and modulate growth hormone and luteinizing hormone release [1][3]. These signals are intriguing for a stress-axis role, but they have not been replicated in large modern trials.

Other areas under study

Older literature explored DSIP for alcohol and opioid withdrawal, depression, and even oncology contexts [1][3]. None of these uses are supported by current FDA-recognized evidence, and none should be considered established.

How does DSIP make you feel?

Reports from older clinical studies describe a calming or 'settled' feeling rather than sedation — users typically do not describe DSIP as knocking them out the way a sleep medication might [3][4]. Because trials were small and subjective experience varies, individual results vary and there is no validated profile of how DSIP 'feels.'

How long does DSIP take to work?

In published research, DSIP has been given by IV infusion or injection, with effects on sleep measures evaluated the same night or over a few nights of repeat dosing [3][4]. The peptide has a short half-life in plasma — on the order of minutes — though downstream effects on sleep architecture may outlast the molecule itself [1]. Reliable timelines for subcutaneous use in humans have not been established.

What are the side effects and risks of DSIP?

Known safety data

Short-term studies reported few acute side effects, with occasional mild headache, nausea, or dizziness [3][4]. Because trials were small and brief, this is not the same as a clean safety record.

Unknowns and research gaps

There are no large, modern, placebo-controlled trials of DSIP. Long-term safety, drug interactions, effects in pregnancy, and effects in people on antidepressants, sleep medications, or opioids are essentially unstudied [1][3]. Material sold as 'research peptide' is not held to pharmaceutical purity, sterility, or potency standards, which adds risk on top of the unknowns about the molecule itself [2].

DSIP dosing in research studies

For education only — this is not a dosing recommendation. In older human trials, DSIP was typically given as IV infusion in the microgram-per-kilogram range over short periods, with subcutaneous protocols described in a smaller subset of studies [3][4]. Because there is no FDA-approved label, no standardized dose exists, and any use outside research requires evaluation by a licensed clinician.

Is DSIP legal? FDA and regulatory status

DSIP is not FDA-approved for any condition. It is not currently on the FDA's 503A Bulks List of substances that compounding pharmacies may use, and it is not a recognized dietary supplement ingredient [2]. Selling DSIP for human use in the US is not permitted; the legal pathway for vendors is to market it as 'research use only,' which carries the restrictions described above.

The FDA's broader peptide review process is active: a reclassification announcement is expected around April 15-16, 2026, and the Pharmacy Compounding Advisory Committee (PCAC) is scheduled to discuss several peptides on July 23-24, 2026 [2]. DSIP's status could change, but as of today it remains non-approved.

How to get DSIP or a clinician-reviewed sleep peptide

Research chemicals vs. compounded peptides

There is a meaningful difference between 'research use only' peptides sold online and compounded peptides dispensed by a licensed 503A pharmacy under a prescription. A 503A compounding pharmacy is a state-licensed pharmacy that prepares medications for individual patients on a clinician's order. Compounded peptides come with pharmacy-level sterility, identity, and potency standards. DSIP itself is not currently available through this pathway because it is not on the 503A Bulks List [2].

Working with a licensed telehealth provider like Chia

If the underlying goal is better sleep, recovery, or stress resilience, a clinician can help sort through evidence-based options — including sleep hygiene, primary-care evaluation for conditions like sleep apnea, and, where appropriate, peptides that are eligible for compounding. Chia is one of several licensed telehealth providers that offer a clinician-reviewed path to compounded peptides where the regulatory pathway allows. A visit is a way to get an honest read on what is and isn't a fit — not a guarantee that any specific peptide will be prescribed.

DSIP vs. other sleep and recovery peptides

What peptides stack well with DSIP?

DSIP itself is not eligible for compounding, so 'stacking' is mostly a research-literature concept rather than a clinical protocol. In published and clinical-practice contexts, DSIP has been discussed alongside Epitalon (for circadian rhythm support, with both targeting sleep-wake biology) and Selank (for stress and anxiety, where DSIP's possible cortisol-modulating effects could overlap) [1][5]. The safety caveat is real: there are no combination-specific trials, side effects of one peptide can compound those of another, and any combined use needs licensed clinician oversight.

Frequently asked questions about DSIP

Keep reading

Longevity Peptides

BPC-157 Side Effects: What the Evidence Actually Shows

Longevity Peptides

TB-500 Peptide: What It Is, How It Works, and What the Research Shows

GLP-1 Weight Loss

How to Get Weight Loss Injections: A Step-by-Step Guide